Retatrutide appears to: Target deep abdominal fat Reduce waist circumference more significantly Improve metabolic syndrome components Safety and Tolerability Side Effects: Similar to GLP-1 Agonists Nausea Vomiting Diarrhea or constipation Fatigue in early weeks Mitigation strategy: Start at low doses and titrate slowly Consider antiemetics in sensitive patients While retatrutides triple action raises theoretical concerns, early data show comparable tolerability to tirzepatide , with no increase in severe adverse events
Yes, semaglutide may cause nausea or vomiting, leading to reduced fluid intake and dehydration, which can concentrate urine and cause a stronger odor
Oxidative stress, as reflected by glutathione status, appeared to be an earlier signal than inflammation in the trajectory of age-related cognitive decline
Environmental Stressors Pollution, heavy metals, and UV radiation all increase the production of free radicals
When will this be approved for weight loss
IBS-C patients had lower serum GLP-1 levels, which was connected with abdominal pain, indicating GLP-1s potential for alleviating pain in these patients